{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:27:38Z","timestamp":1789644458380,"version":"4.0.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":1185,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1469-0691.2010.03422.x","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T09:30:28Z","timestamp":1289640628000},"page":"1372-1380","source":"Crossref","is-referenced-by-count":17,"title":["Decreasing candidaemia rate in abdominal surgery patients after introduction of fluconazole prophylaxis*"],"prefix":"10.1016","volume":"17","author":[{"given":"B.J.","family":"Holzknecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thorup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Steensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hesselfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2010.03422.x_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28\u2010month European Confederation of Medical Mycology (ECMM) hospital\u2010based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib3","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jinf.2009.08.020","article-title":"Excess mortality, length of stay and cost attributable to candidaemia","volume":"59","author":"Hassan","year":"2009","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib5","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1086\/323759","article-title":"Revisiting the source of candidemia: skin or gut?","volume":"33","author":"Nucci","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib6","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment ofCandida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi\u2010institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib8","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1007\/s00134-002-1540-y","article-title":"Prevention of severe Candida infections in nonneutropenic, high\u2010risk, critically ill patients: a randomized, double\u2010blind, placebo\u2010controlled trial in patients treated by selective digestive decontamination","volume":"28","author":"Garbino","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib9","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra\u2010abdominal candidiasis in high\u2010risk surgical patients","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","article-title":"Double\u2010blind placebo\u2010controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients","volume":"233","author":"Pelz","year":"2001","journal-title":"Ann Surg"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00019048-200009040-00006","article-title":"Fluconazole prophylaxis of severeCandida infection in trauma and postsurgical patients: a prospective, double\u2010blind, randomized, placebo\u2010controlled trial","volume":"9","author":"Ables","year":"2000","journal-title":"Infect Dis Clin Pract"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00005373-199401000-00004","article-title":"Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant\/nonburned critically ill surgical and trauma patients","volume":"36","author":"Savino","year":"1994","journal-title":"J Trauma"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00003246-200203000-00008","article-title":"Significance ofCandida recovered from intraoperative specimens in patients with intra\u2010abdominal perforations","volume":"30","author":"Sandven","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib14","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.CCM.0000178352.14703.49","article-title":"Fluconazole prophylaxis in critically ill surgical patients: a meta\u2010analysis","volume":"33","author":"Shorr","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00134-005-2794-y","article-title":"Prophylaxis ofCandida infections in adult trauma and surgical intensive care patients: a systematic review and meta\u2010analysis","volume":"31","author":"Cruciani","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dki491","article-title":"Antifungal agents for preventing fungal infections in non\u2010neutropenic critically ill and surgical patients: systematic review and meta\u2010analysis of randomized clinical trials","volume":"57","author":"Playford","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib17","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"Piarroux","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00268-005-7807-z","article-title":"Early presumptive therapy with fluconazole for occultCandida infection after gastrointestinal surgery","volume":"30","author":"Shan","year":"2006","journal-title":"World J Surg"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00134-008-1339-6","article-title":"Management of invasive candidiasis and candidemia in adult non\u2010neutropenic intensive care unit patients: Part II, Treatment","volume":"35","author":"Guery","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra\u2010abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/01.CCM.0000201889.39443.D2","article-title":"Candida as a risk factor for mortality in peritonitis","volume":"34","author":"Montravers","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1086\/529435","article-title":"Factors associated with candidemia caused by non\u2010albicans Candida species versusCandida albicans in the intensive care unit","volume":"46","author":"Chow","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2008.01954.x","article-title":"Semi\u2010national surveillance of fungaemia in Denmark 2004\u20132006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility","volume":"14","author":"Arendrup","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","author":"Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1469-0691.2007.01899.x","article-title":"EUCAST technical note on fluconazole","volume":"14","author":"European Committee on Antimicrobial Susceptibility Testing\u2010Subcommittee on Antifungal Susceptibility Testing (EUCAST\u2010AFST)","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib28","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27\u2010A3","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2006.11.017","article-title":"Risk of resistance associated with fluconazole prophylaxis: systematic review","volume":"54","author":"Brion","year":"2007","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2010.03422.x_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/109629603322761409","article-title":"Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit","volume":"4","author":"Swoboda","year":"2003","journal-title":"Surg Infect (Larchmt)"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14612209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14612209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T04:20:03Z","timestamp":1559794803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14612209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1198743X14612209"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03422.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}